-
Study aim
-
In this study we aimed to evaluate the efficacy of bilateral greater occipital nerve block in post dural puncture headache (PDPH).
-
Design
-
parallel groups, randomized, controlled trial on 28 patients, phase 3, enrolled between April 2019 to April 2020.
-
Settings and conduct
-
This randomized clinical trial is conducted at Tehran Shariati hospital in 2019-2020. 28 patients with diagnosis of PDPH based on HIS criteria enter the study in two groups. Patients are taken informed consent. Patients are categorized into two groups: the conservative treatment group (conservative treatment including hydration, bed rest and acetaminophene 1 gr/qds) and the occipital nerve block group. VAS (Visual Analogue Scale, a apin severity scale) is used to measure outcome in both groups 10 minutes, 2 hrs, 6 hrs, 12 hrs, 24 hrs and 48 hrs after intervention. Two groups are compared regarding VAS in different time points of study. Statistical analysis is performed with SPSS version 22.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria consist of patients with post dural puncture headache due to IHS criteria.Exclusion criteria include history of greater occipital nerve injection within previous three months, hypersensitivity to the Lidocaine or Triamcinolone, seizure, local infection of the scalp, medication overuse headache, head surgery, severe hepatic failure, unstable vital sings, fever, chronic daily headache or thunderclap headache after dural puncture .
-
Intervention groups
-
Patients are categorized into two groups: the conservative treatment group (conservative treatment including hydration, bed rest and acetaminophene 1 gr/qds) and the occipital nerve block group.
-
Main outcome variables
-
VAS (Visual Analogue Scale) score in 10 min, 2 h. 12 h, 24 h, 48 h